SYN-Tech Chem & Pharm Co Ltd

1777 · TWO · Healthcare / Biotechnology

76.10TWD+1.40 (+1.87%)

Price History

Full chart

Market Stats

Previous Close74.70

Open74.80

Day Range74.80 – 76.30

52-Week Range66.28 – 75.90

Volume86.44K

Market Cap3.30B

P/E (TTM)9.97

Forward P/E19.12

EPS7.42

Dividend Yield5.38%

Beta-0.09

50-Day Avg73.97

200-Day Avg72.55

About

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOJuncheng Hong
Employees223
HeadquartersNo. 168 Kai Yuan Road, Tainan City, Taiwan, 73055, Taiwan
Websitehttps://www.syn-tech.com.tw

Leadership

Juncheng HongManager
Mei Qi ZhuangAccounting Supervisor

Financials

Income Statement

Currency: TWD	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	683.56M	766.79M	694.99M	784.83M	946.41M	983.79M	893.23M	986.30M	1.11B	1.26B	1.30B
Growth (%)	-	+12.17%	-9.36%	+12.93%	+20.59%	+3.95%	-9.20%	+10.42%	+13.02%	+12.83%	+3.39%
Cost of Revenue	427.66M	471.60M	500.74M	540.09M	647.61M	619.13M	609.22M	625.32M	712.14M	770.72M	849.88M
Gross Profit	255.91M	295.19M	194.25M	244.74M	298.81M	364.66M	284.01M	360.98M	402.55M	486.94M	450.36M
Gross Margin	37.44%	38.50%	27.95%	31.18%	31.57%	37.07%	31.80%	36.60%	36.11%	38.72%	34.64%
Operating Expense	86.53M	107.01M	92.77M	95.24M	98.19M	102.29M	115.43M	122.75M	120.69M	135.96M	130.50M
Operating Income	169.38M	188.18M	101.48M	149.50M	200.61M	262.37M	168.59M	238.23M	281.85M	350.98M	319.86M
Operating Margin	24.78%	24.54%	14.60%	19.05%	21.20%	26.67%	18.87%	24.15%	25.29%	27.91%	24.60%
EBITDA	-	224.87M	152.72M	211.06M	270.18M	333.14M	240.04M	319.08M	393.61M	634.37M	482.06M
EBITDA Margin	-	29.33%	21.97%	26.89%	28.55%	33.86%	26.87%	32.35%	35.31%	50.44%	37.07%
Net Income	156.24M	158.47M	59.78M	153.99M	159.47M	186.74M	177.16M	295.29M	251.01M	393.28M	261.61M
Net Income Margin	22.86%	20.67%	8.60%	19.62%	16.85%	18.98%	19.83%	29.94%	22.52%	31.27%	20.12%
R&D	26.66M	33.61M	27.41M	28.58M	24.10M	24.00M	36.48M	36.83M	37.91M	42.51M	38.87M
R&D as % of Total Revenue	3.90%	4.38%	3.94%	3.64%	2.55%	2.44%	4.08%	3.73%	3.40%	3.38%	2.99%
Interest Expense	0	166.00K	1.82M	4.62M	5.39M	3.50M	3.39M	5.92M	5.74M	2.14M	1.00M
Interest Expense % of Total Revenue	0.00%	0.02%	0.26%	0.59%	0.57%	0.36%	0.38%	0.60%	0.51%	0.17%	0.08%

Balance Sheet

Currency: TWD	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.22B	1.29B	1.56B	1.82B	1.86B	1.78B	2.90B	2.78B	2.90B	2.85B	2.96B
Total Liabilities	255.13M	259.92M	559.62M	725.85M	700.89M	541.46M	911.71M	580.13M	583.48M	291.65M	369.57M
Total Equity	969.06M	1.03B	996.24M	1.10B	1.16B	1.24B	1.98B	2.20B	2.32B	2.56B	2.59B
Cash	377.68M	353.61M	136.46M	380.31M	484.67M	619.15M	1.23B	844.96M	666.92M	656.80M	1.05B
Total Debt	-	64.06M	424.48M	551.49M	541.57M	373.98M	765.13M	427.99M	402.75M	-	-
Net Debt	-	-289.56M	288.02M	171.18M	56.91M	-245.17M	-464.73M	-416.97M	-264.17M	-	-

Cash Flow

Currency: TWD	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	149.84M	235.26M	42.89M	188.49M	228.12M	319.21M	156.98M	438.81M	262.29M	622.61M	559.49M
Investing Cash Flow	-120.48M	-125.12M	-526.92M	-27.96M	42.98M	87.27M	-354.91M	-	-	-	-
Financing Cash Flow	-76.47M	-133.57M	266.87M	83.33M	-166.74M	-275.70M	840.04M	-476.17M	-123.66M	-	-
Capital Expenditure	75.95M	185.73M	207.40M	77.33M	63.20M	64.62M	127.22M	477.40M	437.34M	213.75M	58.30M
Free Cash Flow	-	49.53M	-164.50M	111.16M	164.92M	254.59M	29.76M	-38.59M	-175.05M	408.85M	501.19M
Dividends Paid	90.18M	105.21M	105.21M	52.60M	99.20M	105.21M	120.24M	86.13M	133.78M	156.07M	236.34M
FCF to OCF	-	21.05%	-383.51%	58.98%	72.30%	79.76%	18.96%	-8.79%	-66.74%	65.67%	89.58%
Dividend Paid to FCF	-	212.41%	-63.96%	47.32%	60.15%	41.32%	404.04%	-223.22%	-76.42%	38.17%	47.16%

Earnings

Report Date	Oct 26, 2007	Oct 26, 2009	Apr 21, 2010	May 14, 2015	Jul 15, 2015	Nov 13, 2015	Mar 28, 2016	Mar 31, 2020	May 14, 2020	Aug 11, 2020	Nov 10, 2020	Mar 16, 2021	May 14, 2021	Aug 12, 2021	Nov 3, 2021	Mar 28, 2022	May 8, 2022	Aug 2, 2022	Nov 2, 2022	Mar 13, 2023	May 9, 2023	Aug 7, 2023	Nov 6, 2023	Mar 7, 2024
EPS Estimate	0.82	0.55	0.52	1.08	1.03	1.50	1.28	1.50	1.22	-	-	1.24	1.53	-	1.78	-	0.49	0.59	0.73	-	1.15	1.28	1.60	1.45
EPS Actual	-0.09	0.33	0.74	1.29	0.77	1.74	1.39	1.03	1.56	2.26	1.10	1.15	1.66	0.71	0.94	0.05	0.85	1.72	2.54	0.52	1.47	1.51	2.07	0.57
Surprise	-110.98%	-40.00%	42.31%	19.44%	-25.24%	16.00%	8.59%	-31.33%	27.87%	-	-	-7.26%	8.50%	-	-47.19%	-	73.47%	191.53%	247.95%	-	27.83%	17.97%	29.38%	-60.69%
Timing	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap3.30B

Enterprise Value2.45B

Trailing P/E9.97

Forward P/E19.12

Price / Sales2.59

Price / Book1.28

EPS7.42

Book Value57.79

Revenue (TTM)1.27B

Gross Profit (TTM)494.17M

EBITDA501.11M

Profit Margin26.07%

Operating Margin31.30%

Return on Equity13.28%

Return on Assets7.32%

Shares Outstanding44.59M

Shares Float19.89M

Beta-0.09

Dividend Yield5.38%

Dividend Rate4.00

Payout Ratio71.45%

Dividends

20261×

4.00Jul 16, 2026

20251×

5.30Jul 21, 2025

20241×

3.50Jul 19, 2024

20231×

3.00Jul 21, 2023

20221×

1.93Jul 21, 2022

20211×

3.87Sep 16, 2021

20201×

3.38Jul 23, 2020

20191×

3.19Jul 25, 2019

20181×

1.69Jul 26, 2018

20171×

3.38Jul 27, 2017

20161×

3.38Jul 28, 2016

20151×

2.90Jul 30, 2015

20142×

1.89Jul 24, 20141.60Jul 23, 2014

20131×

1.23Aug 1, 2013

20122×

0.95Aug 3, 20120.80Aug 2, 2012

20111×

2.07Jul 12, 2011

20101×

1.53Jun 28, 2010

20091×

0.72Jul 23, 2009

20081×

1.25Jul 7, 2008

Stock Splits

Aug 3, 20121.05:1
Jul 23, 2009110:100